Signaturefd, LLC Ligand Pharmaceuticals Inc Transaction History

Signaturefd, LLC

$5.2 Billion
Q3 2024

A detailed history of Signaturefd, LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Signaturefd, LLC holds 301 shares of LGND stock, worth $36,932. This represents 0.0% of its overall portfolio holdings.

Number of Shares

301

Previous 301 -0.0%

Holding current value

$36,932

Previous $25,000 20.0%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	SELL	$68.53 - $87.91 $822 - $1,054	-12 Reduced 3.83%	301 $25,000
Q4 2023 Jan 31, 2024	BUY	$49.57 - $72.63 $10,310 - $15,107	208 Added 198.1%	313 $22,000
Q2 2023 Aug 01, 2023	SELL	$69.53 - $79.33 $2,572 - $2,935	-37 Reduced 26.06%	105 $7,000
Q4 2022 Jan 27, 2023	BUY	$61.72 - $96.74 $308 - $483	5 Added 3.65%	142 $9,000
Q3 2022 Nov 08, 2022	BUY	$0.01 - $107.56 $0 - $3,979	37 Added 37.0%	137 $12,000
Q2 2022 Aug 10, 2022	SELL	$74.52 - $117.06 $1,192 - $1,872	-16 Reduced 13.79%	100 $9,000
Q1 2022 May 02, 2022	BUY	$94.99 - $151.56 $94 - $151	1 Added 0.87%	116 $13,000
Q3 2021 Oct 28, 2021	SELL	$102.33 - $144.73 $4,707 - $6,657	-46 Reduced 28.57%	115 $16,000
Q2 2021 Jul 26, 2021	BUY	$113.03 - $155.64 $2,260 - $3,112	20 Added 14.18%	161 $21,000
Q1 2021 Apr 30, 2021	SELL	$99.52 - $215.83 $597 - $1,294	-6 Reduced 4.08%	141 $21,000
Q4 2020 Feb 11, 2021	SELL	$80.55 - $106.05 $4,349 - $5,726	-54 Reduced 26.87%	147 $15,000
Q3 2020 Nov 03, 2020	BUY	$89.56 - $126.72 $895 - $1,267	10 Added 5.24%	201 $19,000
Q2 2020 Jul 30, 2020	BUY	$68.28 - $123.65 $11,471 - $20,773	168 Added 730.43%	191 $21,000
Q1 2020 Apr 23, 2020	BUY	$63.37 - $107.88 $1,457 - $2,481	23 New	23 $2,000
Q4 2018 Feb 13, 2019	SELL	$128.36 - $272.13 $96,270 - $204,097	-750 Closed	0 $0
Q3 2018 Nov 15, 2018	BUY	$211.18 - $274.49 $158,385 - $205,867	750 New	750 $206,000

Others Institutions Holding LGND

# of Institutions

257

Shares Held

18.2M

Call Options Held

26.8K

Put Options Held

9.3K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $2.07B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.

Account